The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

AZN FINANCIAL STATEMENTS

AstraZeneca PLC — balance sheet, income statement and cash flow trends

AZNAstraZeneca PLC

🇬🇧 UK · LSE · Healthcare · Drug Manufacturers - General

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
020 B40 B60 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue61.3 B $Gross Profit48.6 B $ · 79%Operating Income13.9 B $ · 23%Pre-tax Income12.6 B $ · 21%Net Income to Owners10.4 B $ · 17%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue61.3 B $+9.3%
Gross Profit48.6 B $+16.2%
Operating Income13.9 B $+12.9%
EBITDA20.4 B $+48.9%
Net Income to Owners10.4 B $+17.9%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
050 B100 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets116.4 B
  • Equity50.6 B $43%
  • Current Liabilities31.7 B $27%
  • Long-term Liabilities34.1 B $29%

Key Figures

YoY change
Total Assets116.4 B $+9.6%
Total Liabilities65.8 B $+1.0%
Total Equity50.6 B $+23.2%
Cash & ST Investments5 B $—
Total Debt32.4 B $—
Net Debt27.5 B $+12.1%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
05 B10 B15 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
05 B10 B13.7 B $Operating-8.2 B $Investing-7.7 B $Financing-2.1 B $Net Change

Key Figures

YoY change
Operating Cash Flow13.7 B $+0.2%
Capital Expenditures5.3 B $+24.9%
Free Cash Flow8.4 B $-10.9%
Dividends Paid4.9 B $-40.7%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on AZN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 4, 26. This content is for informational purposes only and is not investment advice.